GB9311030D0 - Pharmaceutical formulations - Google Patents
Pharmaceutical formulationsInfo
- Publication number
- GB9311030D0 GB9311030D0 GB939311030A GB9311030A GB9311030D0 GB 9311030 D0 GB9311030 D0 GB 9311030D0 GB 939311030 A GB939311030 A GB 939311030A GB 9311030 A GB9311030 A GB 9311030A GB 9311030 D0 GB9311030 D0 GB 9311030D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical formulations
- formulations
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939311030A GB9311030D0 (en) | 1993-05-28 | 1993-05-28 | Pharmaceutical formulations |
PCT/IB1994/000204 WO1994027600A1 (en) | 1993-05-28 | 1994-05-16 | Pharmaceutical formulations with clavulanic acid and an antimycobacterial agent |
EP94918998A EP0675716A1 (en) | 1993-05-28 | 1994-05-16 | Pharmaceutical formulations with clavulanic acid and an antimycobacterial agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939311030A GB9311030D0 (en) | 1993-05-28 | 1993-05-28 | Pharmaceutical formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9311030D0 true GB9311030D0 (en) | 1993-07-14 |
Family
ID=10736272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB939311030A Pending GB9311030D0 (en) | 1993-05-28 | 1993-05-28 | Pharmaceutical formulations |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0675716A1 (en) |
GB (1) | GB9311030D0 (en) |
WO (1) | WO1994027600A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ318282A (en) | 1995-09-07 | 2000-01-28 | Smithkline Beecham Corp | Pharmaceutical formulation containing amoxycillin and clavulanate in a weight ratio of 12:1 and 20:1 |
AR031068A1 (en) * | 1999-04-13 | 2003-09-10 | Beecham Pharm Pte Ltd | A PHARMACEUTICAL FORMULATION OF MODIFIED RELEASE THAT INCLUDES AMOXICILLIN AND POTASSIUM CLAVULANATE IN A RATIO OF 2: 1 TO 20: 1, A COMPRESSED IN LAYERS, THE USE OF AMOXYCLINE AND THE POTASSIUM CLAVULANATE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT COMPACT GRANULES |
US6878386B1 (en) | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
US7250176B1 (en) | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
US6294199B1 (en) | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
EP1330236A2 (en) | 2000-10-12 | 2003-07-30 | Beecham Pharmaceuticals (Pte) Limited | Formulation containing amoxicillin |
-
1993
- 1993-05-28 GB GB939311030A patent/GB9311030D0/en active Pending
-
1994
- 1994-05-16 WO PCT/IB1994/000204 patent/WO1994027600A1/en not_active Application Discontinuation
- 1994-05-16 EP EP94918998A patent/EP0675716A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO1994027600A1 (en) | 1994-12-08 |
EP0675716A1 (en) | 1995-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA953236B (en) | Pharmaceutical formulations | |
ZA951781B (en) | Pharmaceutical formulations | |
GB9323399D0 (en) | Pharmaceutical formulations | |
GB9311030D0 (en) | Pharmaceutical formulations | |
GB9201639D0 (en) | Pharmaceutical formulations | |
GB9413542D0 (en) | Pharmaceutical formulations | |
GB9304799D0 (en) | Pharmaceutical formulations | |
GB9321676D0 (en) | Pharmaceutical formulations | |
GB9301250D0 (en) | Pharmaceutical formulations | |
GB9315119D0 (en) | Pharmaceutical formulations | |
GB9314443D0 (en) | Pharmaceutical formulations | |
GB9312344D0 (en) | Pharmaceutical formulations | |
GB9304800D0 (en) | Pharmaceutical formulations | |
GB9304797D0 (en) | Pharmaceutical formulations | |
GB9302908D0 (en) | Pharmaceutical formulations | |
GB9203212D0 (en) | Pharmaceutical formulations | |
GB9307003D0 (en) | Pharmaceutical formulations | |
GB9221244D0 (en) | Pharmaceutical formulations | |
GB9217602D0 (en) | Pharmaceutical formulations | |
GB9204774D0 (en) | Pharmaceutical formulations | |
GB9207338D0 (en) | Pharmaceutical formulations | |
GB9316253D0 (en) | Pharmaceutical formulation | |
GB9305439D0 (en) | Pharmaceutical formulation | |
GB9322907D0 (en) | Pharmaceutical formulation | |
GB9322906D0 (en) | Pharmaceutical formulation |